« Back to news listing

CardiAQ™ Valve Technologies, Inc. Completes $37.3 Million Series B Round

CardiAQ™ Valve Technologies, Inc., a privately held medical device company developing technologies for percutaneous mitral heart valve replacement, announced today that it received $37.3 million in funding in its second round of equity financing.  OrbiMed led the round and was joined by Versant Ventures, Advent Life Sciences and existing investors.

Read entire article: http://www.businesswire.com/news/home/20120614005818/en/CardiAQ%E2%84%A2-Valve-Technologies-Reports-Cardiovascular-Medicine-Milestone

« Back to news listing